{
    "clinical_study": {
        "@rank": "132907", 
        "acronym": "MILK", 
        "arm_group": {
            "arm_group_label": "Enteral Donor Breastmilk", 
            "arm_group_type": "Experimental", 
            "description": "Donor breast milk will be pasteurized prior to use.\nGiven orally or by nasogastric (NG) or nasojejunal (NJ) tube.\nFeeding will be supervised and will be advanced as quickly as tolerated with a goal of providing 40-50% of nutritional needs from the donor milk.\nIt is recognized that the volume of enteral feeds will need to be adjusted per patient tolerance."
        }, 
        "brief_summary": {
            "textblock": "The investigators hypothesize that children receiving human milk will maintain a greater\n      diversity of helpful bacteria in their gut and have lower levels of inflammatory proteins in\n      the blood compared with children not receiving human milk."
        }, 
        "brief_title": "Human Breastmilk in Children Receiving a Bone Marrow Transplant", 
        "completion_date": {
            "#text": "May 2018", 
            "@type": "Anticipated"
        }, 
        "condition": "Bone Marrow Transplant- Autologous or Allogeneic", 
        "detailed_description": {
            "textblock": "The investigators hypothesize that the gut microbiota during bone marrow transplant could be\n      influenced by administration of enteral donor breast milk.  This study will attempt to\n      address this hypothesis, by feeding donor breast milk to young children undergoing\n      transplant, and serially comparing the gut micobiota in children receiving human milk, with\n      those receiving conventional feeding."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Children less than 5 years old receiving transplant (autologous or allogeneic)\n\n          -  Parents must give informed consent\n\n        Exclusion Criteria:\n\n        - Failure to meet inclusion criteria"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "5 Years", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 5, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02025478", 
            "org_study_id": "2013-2412"
        }, 
        "intervention": {
            "arm_group_label": "Enteral Donor Breastmilk", 
            "description": "A registered dietician will supervise milk provision, and additional calories will be provided by addition of the supplement Prolacta.  To make 28 kcal/oz milk, 40 ml of Prolacta will be mixed with 60 ml human milk to make a total volume of 100 ml.\nIf a nursing mother enrolls on the study, maternal and not donor milk will be given in the maximum volume possible, with Prolacta supplementation if clinically indicated and recommended by the registered dietician.", 
            "intervention_name": "Breastmilk", 
            "intervention_type": "Biological"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "children", 
            "bone marrow transplant", 
            "autologous", 
            "allogeneic", 
            "breastmilk", 
            "hematopoietic stem cell transplantation (HSCT)"
        ], 
        "lastchanged_date": "December 30, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Cincinnati", 
                    "country": "United States", 
                    "state": "Ohio", 
                    "zip": "45229"
                }, 
                "name": "Cincinnati Children's Hospital Medical Center"
            }, 
            "investigator": {
                "last_name": "Stella Davies, MBBS, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "A Pilot Study of Enteral Donor Human Milk in Young Children Receiving Bone Marrow Transplantation", 
        "overall_contact": {
            "email": "jamie.wilhelm@cchmc.org", 
            "last_name": "Jamie Wilhelm", 
            "phone": "513-803-1102"
        }, 
        "overall_official": {
            "affiliation": "Children's Hospital Medical Center, Cincinnati", 
            "last_name": "Stella Davies, MB, BS, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1/Phase 2", 
        "primary_completion_date": {
            "#text": "May 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Bar charts to indicate types and percentage of bacteria in stool samples - will quantify the bacterial diversity using the Shannon index and bacterial chaos using the Bray-Curtis time index.", 
            "measure": "Percentage of lactobacillales", 
            "safety_issue": "No", 
            "time_frame": "21 days after transplant"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02025478"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Mean fold increase above baseline for each cytokine will be calculated and compared to controls", 
                "measure": "Levels of pro-inflammatory cytokines", 
                "safety_issue": "No", 
                "time_frame": "Weekly during study course; up to approximately one year"
            }, 
            {
                "description": "Frequency of bacterial sepsis to be compared against controls", 
                "measure": "Incidence of bacteremia", 
                "safety_issue": "No", 
                "time_frame": "through day 14 post transplant"
            }, 
            {
                "description": "Frequency of GVHD will be compared to controls", 
                "measure": "Incidence of graft versus host disease (GVHD)", 
                "safety_issue": "No", 
                "time_frame": "through study course; approximately one year"
            }
        ], 
        "source": "Children's Hospital Medical Center, Cincinnati", 
        "sponsors": {
            "collaborator": {
                "agency": "Mother's Milk Bank of New England", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Children's Hospital Medical Center, Cincinnati", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "September 2013"
    }
}